Zum Hauptinhalt springen
UB Siegen

The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism-A Review of Literature.

Della Corte, V ; Riolo, R ; et al.
In: International journal of molecular sciences, Jg. 24 (2023-08-29), Heft 17
Online academicJournal
Zugriff:
Zum Volltext

In recent years, the field of venous thromboembolism has undergone numerous innovations, starting from the recent discoveries on the role of biomarkers, passing through the role of metabolomics in expanding our knowledge on pathogenic mechanisms, which have opened up new therapeutic targets. A variety of studies have contributed to characterizing the metabolic phenotype that occurs in venous thromboembolism, identifying numerous pathways that are altered in this setting. Among these pathways are the metabolism of carnitine, tryptophan, purine, and fatty acids. Furthermore, new evidence has emerged with the recent COVID-19 pandemic. Hypercoagulability phenomena induced by this viral infection appear to be related to altered von Willebrand factor activity, alteration of the renin-angiotensin-aldosterone system, and dysregulation of both innate and adaptive immunity. This is the first literature review that brings together the most recent evidence regarding biomarkers, metabolomics, and COVID-19 in the field of venous thromboembolism, while also mentioning current therapeutic protocols.

Competing Interests: The authors declare no conflict of interest.

Titel:
The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism-A Review of Literature.
Autor/in / Beteiligte Person: Della Corte, V ; Riolo, R ; Scaglione, S ; Pecoraro, R ; Tuttolomondo, A
Link:
Zeitschrift: International journal of molecular sciences, Jg. 24 (2023-08-29), Heft 17
Veröffentlichung: Basel, Switzerland : MDPI, [2000-, 2023
Medientyp: academicJournal
ISSN: 1422-0067 (electronic)
DOI: 10.3390/ijms241713411
Schlagwort:
  • Humans
  • Pandemics
  • Metabolomics
  • Biomarkers
  • COVID-19
  • Venous Thromboembolism
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Review
  • Language: English
  • [Int J Mol Sci] 2023 Aug 29; Vol. 24 (17). <i>Date of Electronic Publication: </i>2023 Aug 29.
  • MeSH Terms: COVID-19* ; Venous Thromboembolism* ; Humans ; Pandemics ; Metabolomics ; Biomarkers
  • References: Cell Signal. 2012 May;24(5):981-90. (PMID: 22286106) ; Eur Heart J. 2020 Jan 21;41(4):543-603. (PMID: 31504429) ; Eur J Vasc Endovasc Surg. 2018 May;55(5):703-713. (PMID: 29526653) ; Thromb Res. 2011 Sep;128(3):243-50. (PMID: 21600632) ; J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):640-645. (PMID: 31078515) ; N Am J Med Sci. 2014 Oct;6(10):491-9. (PMID: 25489560) ; Thromb Haemost. 2005 Dec;94(6):1312-7. (PMID: 16411411) ; Arterioscler Thromb Vasc Biol. 2016 May;36(5):1022-9. (PMID: 27013614) ; Nat Rev Cardiol. 2023 Apr;20(4):248-262. (PMID: 36258120) ; Blood. 2000 Jul 1;96(1):170-5. (PMID: 10891447) ; Am J Prev Med. 2010 Apr;38(4 Suppl):S495-501. (PMID: 20331949) ; J Thromb Haemost. 2008 Jul;6(7):1059-71. (PMID: 18419743) ; Eur J Epidemiol. 2017 Aug;32(8):669-681. (PMID: 28540474) ; Trends Cardiovasc Med. 2021 Apr;31(3):143-160. (PMID: 33338635) ; J Thromb Haemost. 2005 Nov;3(11):2497-505. (PMID: 16241948) ; Thromb Res. 2018 May;165:6-13. (PMID: 29544199) ; Prog Lipid Res. 2006 Jan;45(1):42-72. (PMID: 16445986) ; Circ Res. 2018 Oct 26;123(10):1164-1176. (PMID: 30359185) ; Thromb Res. 2011 May;127(5):473-7. (PMID: 21256535) ; Blood. 2007 May 1;109(9):3713-24. (PMID: 17209060) ; Biochem Biophys Res Commun. 2015 Sep 25;465(3):516-22. (PMID: 26278818) ; Blood. 2019 Dec 26;134(26):2399-2413. (PMID: 31877217) ; Thromb Res. 2020 Jul;191:148-150. (PMID: 32381264) ; Prog Mol Biol Transl Sci. 2019;163:21-39. (PMID: 31030749) ; Thromb Haemost. 2009 Oct;102(4):615-9. (PMID: 19806245) ; Cytokine. 1996 Nov;8(11):822-7. (PMID: 9047078) ; Nature. 1990 Feb 22;343(6260):757-60. (PMID: 1689464) ; Thromb Haemost. 2001 Sep;86(3):746-56. (PMID: 11583304) ; Ann Surg. 2023 Feb 1;277(2):e467-e474. (PMID: 35916649) ; Scand J Clin Lab Invest. 2011 Feb;71(1):12-8. (PMID: 21073394) ; J Am Coll Cardiol. 2014 Feb 4;63(4):321-8. (PMID: 24076487) ; J Cell Biol. 1992 Jul;118(2):445-56. (PMID: 1378449) ; Ann Intern Med. 2008 Oct 7;149(7):481-90, W94. (PMID: 18838728) ; Thromb Res. 2010 Apr;125 Suppl 2:S80-3. (PMID: 20434013) ; Br Med J (Clin Res Ed). 1982 Feb 6;284(6313):375-9. (PMID: 6800465) ; Biochem J. 2001 Mar 1;354(Pt 2):359-68. (PMID: 11171115) ; Oncologist. 2016 Feb;21(2):252-7. (PMID: 26764252) ; Br J Haematol. 2008 Sep;142(6):889-903. (PMID: 18564356) ; Ann Intern Med. 2020 Aug 18;173(4):268-277. (PMID: 32374815) ; Pharmacotherapy. 2020 Mar;40(3):204-210. (PMID: 31968126) ; Front Nutr. 2021 Nov 11;8:712600. (PMID: 34859025) ; Nat Med. 2003 Aug;9(8):1020-5. (PMID: 12858167) ; J Proteome Res. 2019 Nov 1;18(11):3809-3820. (PMID: 31617359) ; J Dermatol Sci. 2015 Sep;79(3):241-51. (PMID: 26091964) ; N Engl J Med. 2018 Feb 15;378(7):615-624. (PMID: 29231094) ; Circ Res. 2016 Apr 29;118(9):1340-7. (PMID: 27126645) ; J Vasc Surg Venous Lymphat Disord. 2016 Apr;4(2):221-30. (PMID: 26993871) ; JRSM Open. 2016 Aug 01;7(8):2054270416632670. (PMID: 27540486) ; J Am Heart Assoc. 2016 May 20;5(5):. (PMID: 27207971) ; Trends Mol Med. 2003 Jun;9(6):263-8. (PMID: 12829015) ; Semin Respir Crit Care Med. 2012 Apr;33(2):127-37. (PMID: 22648484) ; J Am Coll Cardiol. 2005 May 3;45(9):1467-71. (PMID: 15862420) ; Circ J. 2014;78(6):1349-56. (PMID: 24705469) ; Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8983-8. (PMID: 22615405) ; Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):413-418. (PMID: 27913509) ; N Engl J Med. 2020 Apr 23;382(17):1599-1607. (PMID: 32223112) ; mBio. 2015 Mar 17;6(2):e02481. (PMID: 25784704) ; Thromb Res. 2011 Mar;127(3):228-34. (PMID: 21237501) ; Nature. 1992 Oct 29;359(6398):848-51. (PMID: 1279433) ; Trends Mol Med. 2004 Apr;10(4):171-8. (PMID: 15059608) ; Chest. 2012 Feb;141(2 Suppl):e419S-e496S. (PMID: 22315268) ; Am J Clin Nutr. 1998 Feb;67(2):221-30. (PMID: 9459369) ; FASEB J. 2005 Mar;19(3):461-3. (PMID: 15611152) ; Eur J Intern Med. 2010 Aug;21(4):289-92. (PMID: 20603037) ; Chest. 2010 Jun;137(6):1382-90. (PMID: 20081101) ; Thromb Res. 2019 May;177:136-144. (PMID: 30901608) ; Clin Chem. 2008 Dec;54(12):2042-8. (PMID: 18948369) ; Angiology. 1953 Aug;4(4):321-36. (PMID: 13065780) ; Lancet. 2012 Aug 11;380(9841):572-80. (PMID: 22607825) ; Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2527-2538. (PMID: 32757649) ; Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1672-8. (PMID: 20466978) ; Vascul Pharmacol. 2019 May;116:1-3. (PMID: 30959115) ; Ann Intern Med. 2003 Jul 1;139(1):19-25. (PMID: 12834314) ; Am J Respir Crit Care Med. 2013 Jun 15;187(12):1369-73. (PMID: 23590273) ; Cell. 2016 Mar 24;165(1):111-124. (PMID: 26972052) ; Blood. 2015 Sep 24;126(13):1595-600. (PMID: 26175037) ; Thromb Haemost. 2002 Jan;87(1):7-12. (PMID: 11848459) ; Nat Commun. 2020 Mar 27;11(1):1620. (PMID: 32221306) ; Chest. 2021 Dec;160(6):e545-e608. (PMID: 34352278) ; Metabolites. 2021 Jul 29;11(8):. (PMID: 34436436) ; Thromb Haemost. 2006 May;95(5):802-6. (PMID: 16676071) ; Nephrol Dial Transplant. 2017 Jan 1;32(1):157-164. (PMID: 28391310) ; Infect Dis Poverty. 2020 Apr 28;9(1):45. (PMID: 32345362) ; J Proteome Res. 2014 Feb 7;13(2):805-16. (PMID: 24367941) ; Crit Care Med. 2010 Feb;38(2 Suppl):S26-34. (PMID: 20083910) ; Thromb Haemost. 2002 Sep;88(3):407-14. (PMID: 12353068) ; J Am Heart Assoc. 2018 Nov 20;7(22):e010317. (PMID: 30571496) ; J Thromb Haemost. 2007 Feb;5(2):296-304. (PMID: 17155963) ; BMJ. 2019 Jul 24;366:l4363. (PMID: 31340984) ; J Vasc Surg Venous Lymphat Disord. 2013 Apr 1;1(2):117-1125. (PMID: 23998134) ; J Thromb Thrombolysis. 2009 Nov;28(4):401-9. (PMID: 19629642) ; Chest. 2012 Feb;141(2 Suppl):e152S-e184S. (PMID: 22315259) ; Eur Heart J. 2018 Dec 14;39(47):4208-4218. (PMID: 28329262) ; PLoS Med. 2006 Aug;3(8):e334. (PMID: 16933968) ; Am Heart J. 2015 Jan;169(1):25-30. (PMID: 25497244) ; J Immunol. 1998 Aug 1;161(3):1471-6. (PMID: 9686613)
  • Contributed Indexing: Keywords: COVID-19; D-Dimer; DVT; cytokines; deep vein thrombosis; metabolomics; thrombin; venous thromboembolism
  • Substance Nomenclature: 0 (Biomarkers)
  • Entry Date(s): Date Created: 20230909 Date Completed: 20230911 Latest Revision: 20230911
  • Update Code: 20231215
  • PubMed Central ID: PMC10488048

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -